InvestorsObserver is giving AVEO Pharmaceuticals, Inc. (AVEO) an Analyst Rating Rank of 80, meaning AVEO is ranked higher by analysts than 80% of stocks. The average projection by analysts for AVEO is $12 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
Investors Observer combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With AVEO Pharmaceuticals, Inc. Stock Today?
AVEO Pharmaceuticals, Inc. (AVEO) stock is trading at $5.87 as of 1:20 PM on Friday, Sep 25, an increase of $0.22, or 3.89% from the previous closing price of $5.65. The stock has traded between $5.65 and $5.90 so far today. Volume today is below average. So far 184,949 shares have traded compared to average volume of 577,584 shares.
Click Here to get the full report on AVEO Pharmaceuticals, Inc. (AVEO) Stock.
